0001645113-20-000051.txt : 20200415 0001645113-20-000051.hdr.sgml : 20200415 20200415170329 ACCESSION NUMBER: 0001645113-20-000051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200413 FILED AS OF DATE: 20200415 DATE AS OF CHANGE: 20200415 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ambrogi Michael J. CENTRAL INDEX KEY: 0001654363 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 20794328 MAIL ADDRESS: STREET 1: 195 COMMERCE WAY CITY: PORTSMOUTH STATE: NH ZIP: 03801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 wf-form4_158698459073166.xml FORM 4 X0306 4 2020-04-13 0 0001645113 NovoCure Ltd NVCR 0001654363 Ambrogi Michael J. C/O NOVOCURE INC. 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Operating Officer Ordinary Shares 2020-04-13 4 M 0 22755 7.15 A 243622 D Ordinary Shares 2020-04-13 4 S 0 22755 69.008 D 220867 D Ordinary Shares 2020-04-14 4 M 0 35745 7.15 A 256612 D Ordinary Shares 2020-04-13 4 S 0 8226 70.182 D 248386 D Ordinary Shares 2020-04-14 4 S 0 27142 70.994 D 221244 D Ordinary Shares 2020-04-14 4 S 0 377 71.753 D 220867 D Options to Buy Ordinary Shares 7.15 2020-04-13 4 M 0 22755 0 D 2027-02-21 Ordinary Shares 22755.0 80259 D Options to Buy Ordinary Shares 7.15 2020-04-14 4 M 0 35745 0 D 2027-02-21 Ordinary Shares 35745.0 44514 D On April 13, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 22,755 shares in multiple trades at prices ranging from $69.00 to $69.42. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. On April 14, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 8,226 shares in multiple trades at prices ranging from $69.62 to $70.61. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. On April 14, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 27,142 shares in multiple trades at prices ranging from $70.62 to $71.51. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. On April 14, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 377 shares in multiple trades at prices ranging from $71.64 to $71.88. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Fully vested as of the date hereof. /s/ Kimberly Burke, Attorney in fact for Michael J. Ambrogi 2020-04-15